Advertisement
New Zealand markets close in 4 hours 44 minutes
  • NZX 50

    11,752.08
    -123.27 (-1.04%)
     
  • NZD/USD

    0.5911
    -0.0009 (-0.15%)
     
  • NZD/EUR

    0.5538
    -0.0003 (-0.06%)
     
  • ALL ORDS

    7,861.00
    -1.30 (-0.02%)
     
  • ASX 200

    7,605.60
    -6.90 (-0.09%)
     
  • OIL

    82.80
    +0.11 (+0.13%)
     
  • GOLD

    2,384.20
    -4.20 (-0.18%)
     
  • NASDAQ

    17,493.62
    -220.04 (-1.24%)
     
  • FTSE

    7,847.99
    +27.63 (+0.35%)
     
  • Dow Jones

    37,753.31
    -45.66 (-0.12%)
     
  • DAX

    17,770.02
    +3.79 (+0.02%)
     
  • Hang Seng

    16,251.84
    +2.87 (+0.02%)
     
  • NIKKEI 225

    37,961.80
    0.00 (0.00%)
     
  • NZD/JPY

    91.1960
    -0.0920 (-0.10%)
     

IQE plc: Total voting rights and Block Admission Return

IQE plc

Total Voting Rights and Block Admission Return

Cardiff, UK
1 July 2022

(“IQE” or the “Company”)

Total Voting Rights

As at 30 June 2022, the Company’s issued share capital consisted of 804,562,832 ordinary shares of 1 pence each (“Ordinary Shares”). The Company holds 4,115 Ordinary Shares in treasury. Therefore the total number Ordinary Shares with voting rights in the Company is 804,558,717.

Shareholders may use this figure (804,558,717) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

ADVERTISEMENT

Block Admission Return

The Company hereby provides an update to its block admission filed on 4 January 2022.

Name of company:

IQE plc

 

 

Name of scheme:

All employee share option plan

 

 

Period of return:

1 January 2022 to 30 June 2022

 

 

Number of Ordinary Shares not issued under scheme at the end of the last period:

7,405,201

 

 

Number of Ordinary Shares issued under scheme during period:

419,252

 

 

Number of Ordinary Shares cancelled under the scheme during period:

Nil

 

 

Number of Ordinary Shares added to the scheme during period:

0

 

 

Balance of Ordinary Shares under scheme not yet issued at end of period:

6,985,949

Number and class of Ordinary Shares originally admitted under scheme and the date of admission:

1,000,000 Ordinary Shares (4 Dec 2009)
2,000,000 Ordinary Shares (11 Oct 2010)
5,000,000 Ordinary Shares (8 Nov 2010)
8,000,000 Ordinary Shares (5 Apr 2011)
6,000,000 Ordinary Shares (16 May 2012)
16,000,000 Ordinary shares (19 Jun 2012)
8,000,000 Ordinary shares (12 Aug 2014)
8,000,000 Ordinary shares (3 Dec 2015)
12,000,000 Ordinary shares (20 April 2017)
14,000,000 Ordinary shares (12 June 2018)
12,000,000 Ordinary shares (25 January 2019)
3,000,000 Ordinary shares (25 January 2020)
8,000,000 Ordinary shares (4 May 2021)

Contacts:

IQE plc
+44 (0) 29 2083 9400
Amy Barlow
        
Peel Hunt LLP (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Edward Knight
Paul Gillam
James Smith

Citigroup Global Markets Limited (Joint Broker)
+44 (0) 20 7986 4000
Christopher Wren
Peter Catterall

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

  • handset devices

  • global telecoms infrastructure

  • connected devices

  • 3D Sensing

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group’s intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.


IQE is headquartered in Cardiff UK, with c. 685 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.